Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CLINFOSS AS
AS
Active
Org 932874059
Tunvegen 16, 4260 Torvastad
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2024
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 2,6M
+141% vs 2024
EBITDA margin
35.9%
+363% vs 2024
Equity ratio
28.8%
Financial strength
Net profit 2025
NOK 724K
+351% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2024
1M
+100%
2025
Key figures
Annual report 2025
Revenue
NOK 2,6M
+141%
EBITDA
NOK 925K
+363%
Net profit
NOK 724K
+351%
Total assets
NOK 1,4M
+300%
Equity
NOK 408K
+121%
Employees
0
—
Company information
Legal name
CLINFOSS AS
Org number
932874059
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23. januar 2024
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Konsulent, klinisk forskningskoordinator innen kliniske studier på legemidler.
Contact
Address
Tunvegen 16, 4260 Torvastad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Karmøy
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
3M
1M
2024
3M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
1M
2025
Income statement
NOK thousands
Item
2024
2025
Revenue
1 067
2 576
Staff expenses
−730
−1 450
EBITDA
200
925
Depreciation & amort.
−0
−0
EBIT
200
925
Net financials
4
4
Profit before tax
204
929
Tax
44
205
Net profit
160
724
Balance sheet
NOK thousands
Item
2024
2025
Total assets
354
1 416
Equity
185
408
Long-term debt
0
0
Short-term debt
169
1 007
Total debt
169
1 007
Financial ratios
5-year trend
EBITDA margin
35.9%
This company
15.8%
Market median
+127% vs market
2024
2025
Equity ratio
28.8%
This company
38.2%
Market median
-25% vs market
2024
2025
Return on equity
177.2%
This company
18.4%
Market median
+863% vs market
2024
2025
Net profit margin
28.1%
This company
8.1%
Market median
+247% vs market
2024
2025
Asset turnover
1.82×
This company
1.12×
Market median
+62% vs market
2024
2025
Debt / equity
2.47×
This company
0.62×
Market median
-298% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KH
Kristin Høivik Fossum
Chief Executive Officer
Chief Executive Officer
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
VF
Vegard Fossum
Board of Directors
2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of CLINFOSS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Kristin Høivik Fossum
Chief Executive Officer
0 companies
Vegard Fossum
Board of Directors
0 companies